The macroeconomic impact of non-communicable diseases in China and India: Estimates, projections, and comparisons

被引：35

作者：

Bloom, David E. ^{[1
]}

Cafiero-Fonseca, Elizabeth T. ^{[7
]}

McGovern, Mark E. ^{[1
,2
]}

Prettner, Klaus ^{[3
]}

Stanciole, Anderson ^{[4
]}

Weiss, Jonathan ^{[5
,6
]}

Bakkila, Samuel ^{[7
]}

Rosenberg, Larry ^{[7
]}

机构：

[1] Harvard Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave,Bldg 1,12th Floor,Suite 1202, Boston, MA 02115 USA

[2] Harvard Ctr Populat & Dev Studies, Cambridge, MA 02138 USA

[3] Vienna Univ Technol, Inst Math Methods Econ, A-1040 Vienna, Austria

[4] Bill & Melinda Gates Fdn, Seattle, WA 98109 USA

[5] London Sch Hyg & Trop Med, London WC1E 7HT, England

[6] UNICEF Supply Div, DK-2100 Copenhagen O, Denmark

[7] Harvard Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA

来源：

JOURNAL OF THE ECONOMICS OF AGEING | 2014年 / 4卷

关键词：

Health and economic development; Non-communicable disease; Economic growth; Cost benefit analysis;

D O I：

10.1016/j.jeoa.2014.08.003

中图分类号：

C921 [人口统计学];

学科分类号：

摘要：

This study provides estimates of the macroeconomic impact of non-communicable diseases (NCDs) in China and India for the period 2012-2030. Our estimates are derived using the World Health Organization's EPIC model of economic growth, which focuses on the negative effects of NCDs on labor supply and capital accumulation. We present results for the five main NCDs (cardiovascular disease, cancer, chronic respiratory disease, diabetes, and mental health). Our undiscounted estimates indicate that the cost of the five main NCDs will total USD 23.03 trillion for China and USD 4.58 trillion for India (in 2010 USD). For both countries, the most costly domain is cardiovascular disease. Our analyses also reveal that the costs are much larger in China than in India mainly because of China's higher and steeper income trajectory, and to a lesser extent its older population. Rough calculations also indicate that WHO's best buys for addressing the challenge of NCDs are highly cost-beneficial. (C) 2014 Elsevier B. V. All rights reserved.

引用

页码：100 / 111

页数：12

共 50 条

[41] Non-communicable disease Requirements for global prevention and control of non-communicable diseases
Lipman, Harald M.
BMJ-BRITISH MEDICAL JOURNAL, 2011, 343
[42] Impact of Mediterranean Diet on Chronic Non-Communicable Diseases and Longevity
Dominguez, Ligia J.
Di Bella, Giovanna
Veronese, Nicola
Barbagallo, Mario
NUTRIENTS, 2021, 13 (06)
[43] Economic Studies on Non-Communicable Diseases and Injuries in India: A Systematic Review
Indrani Gupta
Arjun Roy
Applied Health Economics and Health Policy, 2018, 16 : 303 - 315
[44] Impact of nutritional risk factors on chronic non-communicable diseases
Grosso, Giuseppe
EUROPEAN JOURNAL OF PUBLIC HEALTH, 2019, 29
[45] Rising Health Expenditure Due to Non-Communicable Diseases in India: An Outlook
Barik, Debasis
Arokiasamy, Perianayagam
FRONTIERS IN PUBLIC HEALTH, 2016, 4
[46] Economic Studies on Non-Communicable Diseases and Injuries in India: A Systematic Review
Gupta, Indrani
Roy, Arjun
APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2018, 16 (03) : 303 - 315
[47] Non-communicable diseases: Laws, legislation, and reforms as pathways towards managing non-communicable diseases in Africa
Olonisakin, Tosin Tunrayo
Useh, Ushotanefe
WORLD DEVELOPMENT, 2025, 191
[48] Does gender-equality concern with non-communicable diseases in India?
Gupta, Harish
Nigam, Nitu
LANCET REGIONAL HEALTH - SOUTHEAST ASIA, 2023, 17
[49] Lifestyle and Non-Communicable Diseases: A double edged sword for future India
Chakma, Joy Kumar
Gupta, Sanjay
INDIAN JOURNAL OF COMMUNITY HEALTH, 2014, 26 (04) : 325 - 332
[50] The impact of non-communicable diseases on employment status in South Africa
Lawana, Nozuko
Kapingura, Forget Mingiri
Tsegaye, Asrat
COGENT ECONOMICS & FINANCE, 2023, 11 (02):

← 1 2 3 4 5 →